Clinical Trial Detail

NCT ID NCT01756352
Title FET-PET for Evaluation of Response of Recurrent GBM to Avastin
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Brigham and Women's Hospital
Indications

glioblastoma multiforme

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.